NEW YORK(GenomeWeb) – OncoDNA announced on Wednesday that it has finalized a South Korean distribution agreement with Eone-Diagnomics Genome Center (EDGC).
Under the terms of the agreement, EDGC will have exclusive distribution rights in South Korea for the OncoDEEP Dx panel and other cancer-related tests. Korean physicians will have access to clinically relevant interpretations of test results using the OncoShare web platform.
The OncoDEEP Dx is a 50-gene next-generation sequencing-based diagnostic test that runs on Life Technologies' Ion Torrent instrument.
EDGC offers a range of products and services for personalized medicine based on NGS and other genomic technology. The firm is a joint venture established in 2013 by the Eone Life Science Institute in South Korea and Diagnomics in the US.
Last week, Belgium-based OncoDNA signed a distribution deal for Israel with Progenetics. The firm said it now has 15 exclusive distribution deals.